tradingkey.logo

OPKO Health Inc

OPK
1.300USD
-0.010-0.76%
Close 12/24, 13:00ETQuotes delayed by 15 min
999.31MMarket Cap
LossP/E TTM

OPKO Health Inc

1.300
-0.010-0.76%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of OPKO Health Inc

Currency: USD Updated: 2025-12-24

Key Insights

OPKO Health Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 54/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.67.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

OPKO Health Inc's Score

Industry at a Glance

Industry Ranking
54 / 78
Overall Ranking
231 / 4562
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 7 analysts
Buy
Current Rating
3.670
Target Price
+178.03%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

OPKO Health Inc Highlights

StrengthsRisks
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Fairly Valued
The company’s latest PE is -5.39, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 208.31M shares, decreasing 23.27% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 40.58K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of OPKO Health Inc is 6.53, ranking 62/78 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 151.67M, representing a year-over-year decrease of 12.65%, while its net profit experienced a year-over-year decrease of 13.09%.

Score

Industry at a Glance

Previous score
6.53
Change
0

Financials

9.09

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

4.96

Operational Efficiency

6.60

Growth Potential

4.97

Shareholder Returns

7.04

OPKO Health Inc's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of OPKO Health Inc is 8.03, ranking 18/78 in the Healthcare Providers & Services industry. Its current P/E ratio is -5.39, which is -56.95% below the recent high of -2.32 and -399.86% above the recent low of -26.95.

Score

Industry at a Glance

Previous score
8.03
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 54/78
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

The current earnings forecast score of OPKO Health Inc is 8.00, ranking 27/78 in the Healthcare Providers & Services industry. The average price target for OPKO Health Inc is 3.00, with a high of 8.50 and a low of 1.60.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts
Buy
Current Rating
3.670
Target Price
+178.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

62
Total
5
Median
6
Average
Company name
Ratings
Analysts
OPKO Health Inc
OPK
7
Apple Inc
AAPL
50
Ge Vernova Inc
GEV
34
FMC Corp
FMC
21
Tapestry Inc
TPR
21
Verisk Analytics Inc
VRSK
20
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of OPKO Health Inc is 5.79, ranking 67/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 1.39 and the support level at 1.25, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.83
Change
-0.04

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.004
Sell
RSI(14)
41.895
Neutral
STOCH(KDJ)(9,3,3)
14.064
Oversold
ATR(14)
0.050
High Vlolatility
CCI(14)
-94.677
Neutral
Williams %R
85.622
Oversold
TRIX(12,20)
-0.080
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.312
Sell
MA10
1.330
Sell
MA20
1.338
Sell
MA50
1.370
Sell
MA100
1.395
Sell
MA200
1.407
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

The current institutional shareholding score of OPKO Health Inc is 3.00, ranking 60/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 27.13%, representing a quarter-over-quarter decrease of 65.16%. The largest institutional shareholder is The Vanguard, holding a total of 37.45M shares, representing 4.88% of shares outstanding, with 31.52% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Frost Gamma Investments Trust
220.16M
+0.16%
Rubric Capital Management LP
47.79M
-1.88%
Holbrook (Bruce C)
40.38M
--
The Vanguard Group, Inc.
Star Investors
38.16M
+29.70%
Hsiao (Jane H)
33.13M
--
Frost Group, L.L.C.
30.13M
--
BlackRock Institutional Trust Company, N.A.
28.22M
+13.93%
GJN 2021 Trust
19.91M
--
EGN 2021 Trust
19.91M
--
Geode Capital Management, L.L.C.
10.42M
+23.68%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of OPKO Health Inc is 5.97, ranking 32/78 in the Healthcare Providers & Services industry. The company's beta value is 1.38. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.97
Change
0
Beta vs S&P 500 index
1.38
VaR
+5.00%
240-Day Maximum Drawdown
+38.66%
240-Day Volatility
+48.58%

Return

Best Daily Return
60 days
+5.44%
120 days
+8.63%
5 years
+20.08%
Worst Daily Return
60 days
-6.85%
120 days
-7.03%
5 years
-39.55%
Sharpe Ratio
60 days
-1.35
120 days
-0.06
5 years
-0.17

Risk Assessment

Maximum Drawdown
240 days
+38.66%
3 years
+60.12%
5 years
+83.19%
Return-to-Drawdown Ratio
240 days
-0.30
3 years
+0.02
5 years
-0.18
Skewness
240 days
+0.34
3 years
-1.77
5 years
-0.77

Volatility

Realised Volatility
240 days
+48.58%
5 years
+61.63%
Standardised True Range
240 days
+4.57%
5 years
+8.29%
Downside Risk-Adjusted Return
120 days
-10.22%
240 days
-10.22%
Maximum Daily Upside Volatility
60 days
+21.70%
Maximum Daily Downside Volatility
60 days
+25.51%

Liquidity

Average Turnover Rate
60 days
+0.42%
120 days
+0.47%
5 years
--
Turnover Deviation
20 days
-50.57%
60 days
-39.63%
120 days
-32.94%

Peer Comparison

Healthcare Providers & Services
OPKO Health Inc
OPKO Health Inc
OPK
6.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chemed Corp
Chemed Corp
CHE
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
Lifestance Health Group Inc
LFST
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
Option Care Health Inc
OPCH
8.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of OPKO Health Inc?

The TradingKey Stock Score provides a comprehensive assessment of OPKO Health Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of OPKO Health Inc’s performance and outlook.

How do we generate the financial health score of OPKO Health Inc?

To generate the financial health score of OPKO Health Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects OPKO Health Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of OPKO Health Inc.

How do we generate the company valuation score of OPKO Health Inc?

To generate the company valuation score of OPKO Health Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare OPKO Health Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of OPKO Health Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of OPKO Health Inc.

How do we generate the earnings forecast score of OPKO Health Inc?

To calculate the earnings forecast score of OPKO Health Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on OPKO Health Inc’s future.

How do we generate the price momentum score of OPKO Health Inc?

When generating the price momentum score for OPKO Health Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of OPKO Health Inc’s prices. A higher score indicates a more stable short-term price trend for OPKO Health Inc.

How do we generate the institutional confidence score of OPKO Health Inc?

To generate the institutional confidence score of OPKO Health Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about OPKO Health Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of OPKO Health Inc.

How do we generate the risk management score of OPKO Health Inc?

To assess the risk management score of OPKO Health Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of OPKO Health Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of OPKO Health Inc.
KeyAI